medline.ch Respirationstrakt Zystische Fibrose

	Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development. Nanomedicine (Lond) Munir M, Butcher NJ, Werder RB, Ranganathan SC, Burow R, Venables A, Kaminskas LM. PMID: 41866915 [PubMed - as supplied by publisher]
	Changes to serum lipids, BMI and body composition in adults with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI): A scoping review. J Cyst Fibros Walsh A, Landers C, Lucey N, Griffin O, Carter S, Corish CA. PMID: 41862297 [PubMed - as supplied by publisher]
	Advancements in Sweat Testing Techniques for Cystic Fibrosis: From Classical to Novel Methods. Pediatr Pulmonol Kalyoncu MY, Gokdemir Y. PMID: 41840955 [PubMed - indexed for MEDLINE]
	Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: Results from an open-label extension study. Ann Am Thorac Soc Chmiel JF, McBennett K, Quon BS, Colombo C, De Wachter E, Fajac I, Mondejar-Lopez P, Polineni D, Robinson P, Sutharsan S, Mall MA, McKone EF, Ramsey B, Taylor-Cousar JL, Tullis E, Suresh NE, Zhang Y, Sosnay P, Jennings M, Barry PJ, 445-110 study group. PMID: 41837895 [PubMed - as supplied by publisher]
	Beta cell function and insulin sensitivity during elexacaftor/tezacaftor/ivacaftor therapy in people with cystic fibrosis. Front Endocrinol (Lausanne) Zazzeron L, Grancini V, Trombetta M, Alicandro G, Boselli ML, Cogliati I, Mantovani G, Gramegna A, Blasi F, Bonadonna RC, Orsi E, Daccò V. PMID: 41837123 [PubMed - indexed for MEDLINE]
	Research Progress on the Mechanisms of High Mucus Secretion in the Airway: A Scoping Review. Int J Chron Obstruct Pulmon Dis Ying W, Jing X, Chen L, Zhang J, Yue L, Zhang B. PMID: 41836031 [PubMed - indexed for MEDLINE]
	Mucus and inflammation in the HEMT Era: Persistent barriers to complete airway normalization in cystic fibrosis. J Cyst Fibros Ehre C, Mall MA, McElvaney GN. PMID: 41833488 [PubMed - as supplied by publisher]
	Current State of Clinical Care of People With Cystic Fibrosis. Pharmacotherapy McKinzie CJ, Kam CW, Beringer PM, Wright BA, Bullington WM, Garcia S, Grant JJ, Pettit RS, Young DC. PMID: 41832906 [PubMed - indexed for MEDLINE]
	Prevalence of Overweight and Obesity in the Era of CFTR Modulators in Patients with Cystic Fibrosis. Nutrients Bashir A, Kastl MB, Wang X, Padula L, Reid E, Kofsky R, Pai N, Mascarenhas M. PMID: 41829925 [PubMed - indexed for MEDLINE]
	Early Life Nutrition: The First 1000 Days and Healthy Aging in Cystic Fibrosis. Nutrients Miles CN, Nixon GM, Davidson ZE. PMID: 41829909 [PubMed - indexed for MEDLINE]
	A Diagnostic Dilemma: Concurrent Diagnosis of Cystic Fibrosis and Definitive Kabuki Syndrome Type 1. Int J Mol Sci Vasilyeva T, Kashirskaya N, Mukhina A, Bobreshova A, Melyanovskaya Y, Karpova O, Kazakov D, Marakhonov A, Pershin D, Kondratyeva E, Mikhalchuk K, Selina E, Sibgatullina F, Shakirova A, Vafina Z, Shcherbina A, Zinchenko R. PMID: 41828725 [PubMed - indexed for MEDLINE]
	Hypochloremic Hypokalemic Metabolic Alkalosis as a Manifestation of CFTR-Related Disorder. Pediatr Pulmonol Capraz Yavuz B, Dogru D, Sunman B, Alboga D, Kayaoglu MY, Emiralioglu N, Yalcin E, Ozcelik U. PMID: 41816939 [PubMed - indexed for MEDLINE]
	[Evolution of thoracic computed tomography after therapy with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis]. Rev Med Liege Thimmesch M, Cheping Simo C, Boulay M, Pirson J, Palem A. PMID: 41815026 [PubMed - indexed for MEDLINE]
	Decoding liver injury in cystic fibrosis: How to tell drug-induced liver injury from cystic fibrosis liver disease. World J Gastroenterol Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P. PMID: 41809454 [PubMed - indexed for MEDLINE]
	Genetic and clinical characteristics of pediatric patients with cystic fibrosis: a single-center retrospective study in China. Orphanet J Rare Dis Liu J, Ma L, Yu W, Zhou J, Zhou G, Tuhongjiang Y, Maitusong G, Wang Z, Aizeze S, Tian D, Zhang X, Yang H. PMID: 41807956 [PubMed - as supplied by publisher]
	Integrating cognitive behavioral therapy into specialty care for adolescents with cystic fibrosis: a feasibility trial. J Pediatr Psychol Friedman D, Quittner AL, Bruce AS, Smith BA, He J, Chaudhary N, Boutwell A, Wei R, Mullen TMD, Roach CM, Behrman M, Georgiopoulos AM. PMID: 41806380 [PubMed - as supplied by publisher]
	CFTR Modulators in Brazil: Not for Everyone-A Comparison of Ineligibility Across Different Regions. Pediatr Pulmonol Souza EL, Bomfim VHV, Monte LFV, Mota LR, Nunes GSM, Regina Terse-Ramos, Procianoy EDFA, Silva-Filho LVRFD. PMID: 41806325 [PubMed - indexed for MEDLINE]
	Advancing Mental Healthcare for Individuals With Cystic Fibrosis in Low- and Middle-Income Countries. Pediatr Pulmonol Quittner AL, Graziano S, Mohan MP, Smith BA. PMID: 41804860 [PubMed - indexed for MEDLINE]
	Disparities in Access to Cystic Fibrosis Therapy Across Countries. Pediatr Pulmonol Karadag B. PMID: 41797558 [PubMed - indexed for MEDLINE]
	Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy. Pediatr Pulmonol Bailey J, Rose NR, Chalamalla AR, Anderson JD, Baker E, Guimbellot JS. PMID: 41795678 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 19805

Seite 1 von 991



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung